Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man
- 1 January 1994
- journal article
- Published by Elsevier in Metabolism
- Vol. 43 (1), 104-108
- https://doi.org/10.1016/0026-0495(94)90164-3
Abstract
No abstract availableKeywords
Funding Information
- Sundhed og Sygdom, Det Frie Forskningsråd
- NoVo Foundation
This publication has 13 references indexed in Scilit:
- Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.JCI Insight, 1993
- Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes MellitusNew England Journal of Medicine, 1992
- Insulinotropic Action of Glucagonlike Peptide-I-(7–37) in Diabetic and Nondiabetic SubjectsDiabetes Care, 1992
- Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine.JCI Insight, 1991
- Hepatic glucose production in insulin-resistant statesDiabetes/Metabolism Research and Reviews, 1989
- Effect of Truncated Glucagon-Like Peptide-1 [Proglucagon-(78–107) amide] on Endocrine Secretion from Pig Pancreas, Antrum, and Nonantral StomachEndocrinology, 1988
- Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gutFEBS Letters, 1987
- Glucagon-Like Peptides GLP-1 and GLP-2, Predicted Products of the Glucagon Gene, Are Secreted Separately from Pig Small Intestine but Not Pancreas*Endocrinology, 1986
- Effect of Arginine on Glucose Turnover and Plasma Free Fatty Acids in Normal DogsDiabetes, 1973
- INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT*Annals of the New York Academy of Sciences, 1959